Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Zenz

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Leukemia|November 29, 2016
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locusS Drennan, A D'Avola, Y Gao, et al.
Leukemia|July 20, 2012
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevanceF G Rücker, A C Russ, S Cocciardi, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Bone Marrow Transplantation|July 7, 2015
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapseM Hahn, S Böttcher, S Dietrich, et al.
Cell Death & Disease|August 7, 2015
Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplificationG D te Raa, P D Moerland, A C Leeksma, et al.
Leukemia|June 22, 2013
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximabA M Fink, S Böttcher, M Ritgen, et al.
Leukemia|May 15, 2015
p53-dependent non-coding RNA networks in chronic lymphocytic leukemiaC J Blume, A Hotz-Wagenblatt, J Hüllein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparisonI Herth, S Dietrich, A Benner, et al.
Leukemia|August 26, 2016
Dissection of CD20 regulation in lymphoma using RNAiM Słabicki, K S Lee, A Jethwa, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Leukemia|November 29, 2016
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locusS Drennan, A D'Avola, Y Gao, et al.
Leukemia|July 20, 2012
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevanceF G Rücker, A C Russ, S Cocciardi, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Bone Marrow Transplantation|July 7, 2015
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapseM Hahn, S Böttcher, S Dietrich, et al.
Cell Death & Disease|August 7, 2015
Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplificationG D te Raa, P D Moerland, A C Leeksma, et al.
Leukemia|June 22, 2013
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximabA M Fink, S Böttcher, M Ritgen, et al.
Leukemia|May 15, 2015
p53-dependent non-coding RNA networks in chronic lymphocytic leukemiaC J Blume, A Hotz-Wagenblatt, J Hüllein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparisonI Herth, S Dietrich, A Benner, et al.
Leukemia|August 26, 2016
Dissection of CD20 regulation in lymphoma using RNAiM Słabicki, K S Lee, A Jethwa, et al.
Pageof 4